MAPK3 and cancer: This interpretation has supporting evidence: ERK1/2 played a crucial role in TRX-1-mediated cell proliferation through the regulation of cell cycle modification with cyclin D1, which is a target of β-catenin/Tcf-dependent transcription in cancer cells34-35.